FDA Planning To Solicit Information Aimed At Cutting Needlestick Risk
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to issue an advance notice of proposed rulemaking (ANPRM) to collect information on further steps to reduce the risk of needlestick injuries, the agency announced Sept 5. The advance notice will seek comments on whether FDA should develop a standard for devices that may cause sharps injury.
You may also be interested in...
BD’s Sharp Thinking: Transition From Traditional Needle-Bearing Devices
Becton Dickinson's decision to discontinue sales of its conventional Insyte IV catheters beginning in September is indicative of a trend away from standard needle-bearing offerings in the U.S. in favor of safety-engineered designs
BD’s Sharp Thinking: Transition From Traditional Needle-Bearing Devices
Becton Dickinson's decision to discontinue sales of its conventional Insyte IV catheters beginning in September is indicative of a trend away from standard needle-bearing offerings in the U.S. in favor of safety-engineered designs
OSHA Regs Will Not Keep Unsafe Sharps From Workplace - HRG Petition
FDA should remove from the market all blood collection devices and I.V. catheters for which safer alternatives exist, Public Citizen's Health Research Group is urging in a Nov. 29 petition to Commissioner Jane Henney.